http://orcid.org/0000-0002-1808-0972
Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yu Xia, He Wang, Jing Zhang & Yongjun Wang. (2023) Prognostic value and adverse events of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in primary advanced and platinum-sensitive recurrent epithelial ovarian cancer: a systematic review and meta-analysis. International Journal of Hyperthermia 40:1.
Read now
Read now
H. Petra Kok, Marcus Beck, Daan R. Löke, Roxan F. C. P. A. Helderman, Geertjan van Tienhoven, Pirus Ghadjar, Peter Wust & Hans Crezee. (2020) Locoregional peritoneal hyperthermia to enhance the effectiveness of chemotherapy in patients with peritoneal carcinomatosis: a simulation study comparing different locoregional heating systems. International Journal of Hyperthermia 37:1, pages 76-88.
Read now
Read now
Articles from other publishers (16)
Joannie Neveu, Elizabeth Tremblay, Frederic Mercier, Sébastien Garneau & Beatrice Cormier. (2023) Developing a hyperthermic intraperitoneal chemotherapy (HIPEC) gynecologic oncology program: a Canadian experience. International Journal of Gynecologic Cancer 33:12, pages 1957-1965.
Crossref
Crossref
Stojan Latincic, Maja Pavlov, Jovica Vasiljevic, Dragan Vasin, Maja Dimic-Cumic, Marjan Micev, Milena Papovic, Miljan Doskovic, Stefan Bugarin, Stefan Milosevic & Dragutin Kecmanovic. (2023) Extreme Leukocytosis and Gangrenous Cholecystitis Associated with Cytoreductive Surgery and HIPEC-Treated Mucinos Ovary Cancer: Case Report and Literature Review. Clinics and Practice 13:5, pages 1137-1145.
Crossref
Crossref
Changchun Jian, Hai Mou, Ye Zhang, Qingxin Fan & Yunsheng Ou. (2023) Survival and complications of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with intra-abdominal malignancies: A meta-analysis of randomized controlled trials. Frontiers in Pharmacology 14.
Crossref
Crossref
S. Lot Aronson, Ruby M. van Stein, Gabe S. Sonke & Willemien J. van Driel. (2022)
Future of
HIPEC
for ovarian cancer
. BJOG: An International Journal of Obstetrics & Gynaecology 130:2, pages 135-140.
Crossref
Crossref
P. Filis, D. Mauri, G. Markozannes, M. Tolia, N. Filis & K. Tsilidis. (2022) Hyperthermic intraperitoneal chemotherapy (HIPEC) for the management of primary advanced and recurrent ovarian cancer: a systematic review and meta-analysis of randomized trials. ESMO Open 7:5, pages 100586.
Crossref
Crossref
Amine Souadka, Hajar Essangri, Mohammed Anass Majbar, Amine Benkabbou, Saber Boutayeb, Benoit You, Olivier Glehen, Raouf Mohsine & Naoual Bakrin. (2022) Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in Ovarian Cancer: An Umbrella Review of Meta-Analyses. Frontiers in Oncology 12.
Crossref
Crossref
Cascales Campos Pedro Antonio, González Gil Alida, Gil Gómez Elena, González Sánchez Rocío, Martínez García Jerónimo, Alonso Romero José Luis, Nieto Díaz Aníbal, Barceló Valcárcel Francisco, Gómez Ruiz Álvaro Jesús, Ramírez Romero Pablo & Gil Martínez José. (2021) Cytoreductive Surgery With or Without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer: A Phase 3 Clinical Trial. Annals of Surgical Oncology 29:4, pages 2617-2625.
Crossref
Crossref
Mingchen Ba, Shuzhong Cui, Hui Long, Yuanfeng Gong, Yinbing Wu, Kunpeng Lin, Yinuo Tu, Bohuo Zhang & Wanbo Wu. (2021) Safety and Effectiveness of High-Precision Hyperthermic Intraperitoneal Perfusion Chemotherapy in Peritoneal Carcinomatosis: A Real-World Study. Frontiers in Oncology 11.
Crossref
Crossref
Philipp Horvath, Can Yurttas, Stefan Beckert, Alfred Königsrainer & Ingmar Königsrainer. (2021) Twelve-Year Single Center Experience Shows Safe Implementation of Developed Peritoneal Surface Malignancy Treatment Protocols for Gastrointestinal and Gynecological Primary Tumors. Cancers 13:10, pages 2471.
Crossref
Crossref
Michael Friedrich, Dominique Friedrich, Clayton Kraft, Walther Kuhn & Christoph Rogmans. 2021. Ovarian Cancer - Updates in Tumour Biology and Therapeutics [Working Title]. Ovarian Cancer - Updates in Tumour Biology and Therapeutics [Working Title].
Carlos A. Munoz-Zuluaga, Armando Sardi, Michelle Sittig, Vadim Gushchin, Mary C. King, Carol Nieroda, Felipe Lopez-Ramirez & Teresa P. Diaz-Montes. (2020) Critical Analysis of Stage IV Epithelial Ovarian Cancer Patients after Treatment with Neoadjuvant Chemotherapy followed by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC). International Journal of Surgical Oncology 2020, pages 1-14.
Crossref
Crossref
Alisa N. Blumenthaler, Casey J. Allen, Naruhiko Ikoma, Mariela Blum, Prajnan Das, Bruce D. Minsky, Paul F. Mansfield, Jaffer A. Ajani & Brian D. Badgwell. (2020) Laparoscopic HIPEC for Low-Volume Peritoneal Metastasis in Gastric and Gastroesophageal Adenocarcinoma. Annals of Surgical Oncology 27:13, pages 5047-5056.
Crossref
Crossref
Jan B. Vermorken, Peter van Dam & Alison Brand. (2020) HIPEC in advanced epithelial ovarian cancer: why is there controversy?. Current Opinion in Oncology 32:5, pages 451-458.
Crossref
Crossref
Alina Bisag, Cristiana Bucci, Sara Coluccelli, Giulia Girolimetti, Romolo Laurita, Pierandrea De Iaco, Anna Myriam Perrone, Matteo Gherardi, Lorena Marchio, Anna Maria Porcelli, Vittorio Colombo & Giuseppe Gasparre. (2020) Plasma-activated Ringer’s Lactate Solution Displays a Selective Cytotoxic Effect on Ovarian Cancer Cells. Cancers 12:2, pages 476.
Crossref
Crossref
Abdulaziz Babaier & Prafull Ghatage. (2020) Mucinous Cancer of the Ovary: Overview and Current Status. Diagnostics 10:1, pages 52.
Crossref
Crossref
A.L. Oei, H.P. Kok, S.B. Oei, M.R. Horsman, L.J.A. Stalpers, N.A.P. Franken & J. Crezee. (2020) Molecular and biological rationale of hyperthermia as radio- and chemosensitizer. Advanced Drug Delivery Reviews 163-164, pages 84-97.
Crossref
Crossref